{"entity":{"type":"insider","cik":"0001478448","url":"/insider/0001478448","json_url":"/insider/0001478448.json","name":"MCCOURT Thomas A","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":59,"n_filings":36,"first":"2013-03-13","last":"2026-02-25","span_basis":"filed_date"},"name_variants":[{"name":"MCCOURT Thomas A","source":"filing","n_filings":36,"first_seen":"2013-03-13","last_seen":"2026-02-25"}],"transactions":[{"id":5943543,"accession":"0001193125-26-071496","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-071496","line_url":"/filing/0001193125-26-071496#line-2","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478448","owner_name":"MCCOURT Thomas A","owner_display_name":"MCCOURT Thomas A","owner_url":"/insider/0001478448","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":103526.0,"shares_display":"103,526","price_per_share":3.66,"price_display":"3.66","price_state":"stated","total_value":378905.16,"total_display":"378,905.16","total_whole":"378,905","shares_owned_after":1489002.0,"shares_owned_after_display":"1,489,002","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-24","filed_date":"2026-02-25","scope":"insider"},{"id":5943540,"accession":"0001193125-26-071496","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-071496","line_url":"/filing/0001193125-26-071496#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478448","owner_name":"MCCOURT Thomas A","owner_display_name":"MCCOURT Thomas A","owner_url":"/insider/0001478448","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":94757.0,"shares_display":"94,757","price_per_share":3.81,"price_display":"3.81","price_state":"stated","total_value":361024.17,"total_display":"361,024.17","total_whole":"361,024","shares_owned_after":1592528.0,"shares_owned_after_display":"1,592,528","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-23","filed_date":"2026-02-25","scope":"insider"},{"id":5158518,"accession":"0000950170-25-075191","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-075191","line_url":"/filing/0000950170-25-075191#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478448","owner_name":"MCCOURT Thomas A","owner_display_name":"MCCOURT Thomas A","owner_url":"/insider/0001478448","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13353.0,"shares_display":"13,353","price_per_share":0.58,"price_display":"0.58","price_state":"stated","total_value":7744.74,"total_display":"7,744.74","total_whole":"7,745","shares_owned_after":1147281.0,"shares_owned_after_display":"1,147,281","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-16","filed_date":"2025-05-20","scope":"insider"},{"id":5030564,"accession":"0000950170-25-019237","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-019237","line_url":"/filing/0000950170-25-019237#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478448","owner_name":"MCCOURT Thomas A","owner_display_name":"MCCOURT Thomas A","owner_url":"/insider/0001478448","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":139064.0,"shares_display":"139,064","price_per_share":1.76,"price_display":"1.76","price_state":"stated","total_value":244752.64,"total_display":"244,752.64","total_whole":"244,753","shares_owned_after":1160634.0,"shares_owned_after_display":"1,160,634","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-10","filed_date":"2025-02-12","scope":"insider"},{"id":2677326,"accession":"0000950170-24-063485","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-063485","line_url":"/filing/0000950170-24-063485#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478448","owner_name":"MCCOURT Thomas A","owner_display_name":"MCCOURT Thomas A","owner_url":"/insider/0001478448","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":67618.0,"shares_display":"67,618","price_per_share":6.45,"price_display":"6.45","price_state":"stated","total_value":436136.1,"total_display":"436,136.10","total_whole":"436,136","shares_owned_after":1150330.0,"shares_owned_after_display":"1,150,330","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-20","filed_date":"2024-05-22","scope":"insider"},{"id":2080546,"accession":"0000950170-24-015542","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-015542","line_url":"/filing/0000950170-24-015542#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478448","owner_name":"MCCOURT Thomas A","owner_display_name":"MCCOURT Thomas A","owner_url":"/insider/0001478448","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":177164.0,"shares_display":"177,164","price_per_share":15.24,"price_display":"15.24","price_state":"stated","total_value":2699979.36,"total_display":"2,699,979.36","total_whole":"2,699,979","shares_owned_after":832774.0,"shares_owned_after_display":"832,774","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-12","filed_date":"2024-02-14","scope":"insider"},{"id":7835466,"accession":"0001209191-23-033396","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-033396","line_url":"/filing/0001209191-23-033396#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478448","owner_name":"MCCOURT Thomas A","owner_display_name":"MCCOURT Thomas A","owner_url":"/insider/0001478448","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26632.0,"shares_display":"26,632","price_per_share":10.7,"price_display":"10.70","price_state":"stated","total_value":284962.4,"total_display":"284,962.40","total_whole":"284,962","shares_owned_after":758284.0,"shares_owned_after_display":"758,284","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-30","filed_date":"2023-06-01","scope":"insider"},{"id":7953960,"accession":"0001209191-23-031875","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-031875","line_url":"/filing/0001209191-23-031875#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478448","owner_name":"MCCOURT Thomas A","owner_display_name":"MCCOURT Thomas A","owner_url":"/insider/0001478448","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36000.0,"shares_display":"36,000","price_per_share":10.12,"price_display":"10.12","price_state":"stated","total_value":364320.0,"total_display":"364,320.00","total_whole":"364,320","shares_owned_after":784916.0,"shares_owned_after_display":"784,916","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-22","filed_date":"2023-05-24","scope":"insider"},{"id":8076833,"accession":"0001209191-23-028453","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-028453","line_url":"/filing/0001209191-23-028453#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478448","owner_name":"MCCOURT Thomas A","owner_display_name":"MCCOURT Thomas A","owner_url":"/insider/0001478448","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21148.0,"shares_display":"21,148","price_per_share":10.62,"price_display":"10.62","price_state":"stated","total_value":224591.76,"total_display":"224,591.76","total_whole":"224,592","shares_owned_after":820916.0,"shares_owned_after_display":"820,916","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-08","filed_date":"2023-05-10","scope":"insider"},{"id":8331928,"accession":"0001209191-23-021524","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-021524","line_url":"/filing/0001209191-23-021524#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478448","owner_name":"MCCOURT Thomas A","owner_display_name":"MCCOURT Thomas A","owner_url":"/insider/0001478448","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":46129.0,"shares_display":"46,129","price_per_share":10.67,"price_display":"10.67","price_state":"stated","total_value":492196.43,"total_display":"492,196.43","total_whole":"492,196","shares_owned_after":842064.0,"shares_owned_after_display":"842,064","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-27","filed_date":"2023-03-29","scope":"insider"},{"id":8019287,"accession":"0001209191-23-016696","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-016696","line_url":"/filing/0001209191-23-016696#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478448","owner_name":"MCCOURT Thomas A","owner_display_name":"MCCOURT Thomas A","owner_url":"/insider/0001478448","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33756.0,"shares_display":"33,756","price_per_share":11.22,"price_display":"11.22","price_state":"stated","total_value":378742.32,"total_display":"378,742.32","total_whole":"378,742","shares_owned_after":647598.0,"shares_owned_after_display":"647,598","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-03","filed_date":"2023-03-07","scope":"insider"},{"id":7994656,"accession":"0001209191-23-014283","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-014283","line_url":"/filing/0001209191-23-014283","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478448","owner_name":"MCCOURT Thomas A","owner_display_name":"MCCOURT Thomas A","owner_url":"/insider/0001478448","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31227.0,"shares_display":"31,227","price_per_share":11.31,"price_display":"11.31","price_state":"stated","total_value":353177.37,"total_display":"353,177.37","total_whole":"353,177","shares_owned_after":685942.0,"shares_owned_after_display":"685,942","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-28","filed_date":"2023-03-01","scope":"insider","n_lines":2},{"id":7994654,"accession":"0001209191-23-014283","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-014283","line_url":"/filing/0001209191-23-014283","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478448","owner_name":"MCCOURT Thomas A","owner_display_name":"MCCOURT Thomas A","owner_url":"/insider/0001478448","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30004.0,"shares_display":"30,004","price_per_share":11.41,"price_display":"11.41","price_state":"stated","total_value":342345.64,"total_display":"342,345.64","total_whole":"342,346","shares_owned_after":716990.0,"shares_owned_after_display":"716,990","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-27","filed_date":"2023-03-01","scope":"insider","n_lines":2},{"id":8605231,"accession":"0001209191-23-002543","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-002543","line_url":"/filing/0001209191-23-002543#line-2","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478448","owner_name":"MCCOURT Thomas A","owner_display_name":"MCCOURT Thomas A","owner_url":"/insider/0001478448","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":110962.0,"shares_display":"110,962","price_per_share":12.07,"price_display":"12.07","price_state":"stated","total_value":1339311.34,"total_display":"1,339,311.34","total_whole":"1,339,311","shares_owned_after":712440.0,"shares_owned_after_display":"712,440","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-05","filed_date":"2023-01-09","scope":"insider"},{"id":6353635,"accession":"0001209191-22-052718","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-052718","line_url":"/filing/0001209191-22-052718#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478448","owner_name":"MCCOURT Thomas A","owner_display_name":"MCCOURT Thomas A","owner_url":"/insider/0001478448","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18899.0,"shares_display":"18,899","price_per_share":10.41,"price_display":"10.41","price_state":"stated","total_value":196738.59,"total_display":"196,738.59","total_whole":"196,739","shares_owned_after":712440.0,"shares_owned_after_display":"712,440","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-03","filed_date":"2022-10-05","scope":"insider"},{"id":6613201,"accession":"0001209191-22-048716","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-048716","line_url":"/filing/0001209191-22-048716#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478448","owner_name":"MCCOURT Thomas A","owner_display_name":"MCCOURT Thomas A","owner_url":"/insider/0001478448","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26446.0,"shares_display":"26,446","price_per_share":10.65,"price_display":"10.65","price_state":"stated","total_value":281649.9,"total_display":"281,649.90","total_whole":"281,650","shares_owned_after":731339.0,"shares_owned_after_display":"731,339","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-01","filed_date":"2022-09-06","scope":"insider"},{"id":6824976,"accession":"0001209191-22-044162","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-044162","line_url":"/filing/0001209191-22-044162#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478448","owner_name":"MCCOURT Thomas A","owner_display_name":"MCCOURT Thomas A","owner_url":"/insider/0001478448","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23229.0,"shares_display":"23,229","price_per_share":11.35,"price_display":"11.35","price_state":"stated","total_value":263649.15,"total_display":"263,649.15","total_whole":"263,649","shares_owned_after":757785.0,"shares_owned_after_display":"757,785","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-01","filed_date":"2022-08-03","scope":"insider"},{"id":6672355,"accession":"0001209191-22-040558","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-040558","line_url":"/filing/0001209191-22-040558#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478448","owner_name":"MCCOURT Thomas A","owner_display_name":"MCCOURT Thomas A","owner_url":"/insider/0001478448","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19959.0,"shares_display":"19,959","price_per_share":11.58,"price_display":"11.58","price_state":"stated","total_value":231125.22,"total_display":"231,125.22","total_whole":"231,125","shares_owned_after":778922.0,"shares_owned_after_display":"778,922","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-30","filed_date":"2022-07-05","scope":"insider"},{"id":6784887,"accession":"0001209191-22-031844","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-031844","line_url":"/filing/0001209191-22-031844","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478448","owner_name":"MCCOURT Thomas A","owner_display_name":"MCCOURT Thomas A","owner_url":"/insider/0001478448","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36308.0,"shares_display":"36,308","price_per_share":11.5,"price_display":"11.50","price_state":"stated","total_value":417542.0,"total_display":"417,542.00","total_whole":"417,542","shares_owned_after":810729.0,"shares_owned_after_display":"810,729","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-23","filed_date":"2022-05-25","scope":"insider","n_lines":3},{"id":6542458,"accession":"0001209191-22-014653","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-22-014653","line_url":"/filing/0001209191-22-014653","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478448","owner_name":"MCCOURT Thomas A","owner_display_name":"MCCOURT Thomas A","owner_url":"/insider/0001478448","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":48424.0,"shares_display":"48,424","price_per_share":10.77,"price_display":"10.77","price_state":"stated","total_value":521526.48,"total_display":"521,526.48","total_whole":"521,526","shares_owned_after":602806.0,"shares_owned_after_display":"602,806","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-28","filed_date":"2022-03-02","scope":"insider","n_lines":4},{"id":4589348,"accession":"0001209191-21-071074","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-071074","line_url":"/filing/0001209191-21-071074#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478448","owner_name":"MCCOURT Thomas A","owner_display_name":"MCCOURT Thomas A","owner_url":"/insider/0001478448","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":46327.0,"shares_display":"46,327","price_per_share":11.41,"price_display":"11.41","price_state":"stated","total_value":528591.07,"total_display":"528,591.07","total_whole":"528,591","shares_owned_after":574454.0,"shares_owned_after_display":"574,454","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-22","filed_date":"2021-12-23","scope":"insider"},{"id":4588705,"accession":"0001209191-21-066783","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-066783","line_url":"/filing/0001209191-21-066783#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478448","owner_name":"MCCOURT Thomas A","owner_display_name":"MCCOURT Thomas A","owner_url":"/insider/0001478448","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52644.0,"shares_display":"52,644","price_per_share":11.58,"price_display":"11.58","price_state":"stated","total_value":609617.52,"total_display":"609,617.52","total_whole":"609,618","shares_owned_after":618545.0,"shares_owned_after_display":"618,545","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-23","filed_date":"2021-11-24","scope":"insider"},{"id":4093504,"accession":"0001209191-21-035896","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-035896","line_url":"/filing/0001209191-21-035896#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478448","owner_name":"MCCOURT Thomas A","owner_display_name":"MCCOURT Thomas A","owner_url":"/insider/0001478448","role":"Officer (President and Interim CEO)","role_mark":"O","role_mark_label":"Officer (President and Interim CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and Interim CEO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1716.0,"shares_display":"1,716","price_per_share":12.25,"price_display":"12.25","price_state":"stated","total_value":21021.0,"total_display":"21,021.00","total_whole":"21,021","shares_owned_after":566499.0,"shares_owned_after_display":"566,499","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-24","filed_date":"2021-05-26","scope":"insider"},{"id":4219587,"accession":"0001179110-21-004537","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001179110-21-004537","line_url":"/filing/0001179110-21-004537","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001478448","owner_name":"MCCOURT Thomas A","owner_display_name":"MCCOURT Thomas A","owner_url":"/insider/0001478448","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":119.25669466666666,"price_display":"119.26","price_state":"stated","total_value":894425.21,"total_display":"894,425.21","total_whole":"894,425","shares_owned_after":7387.0,"shares_owned_after_display":"7,387","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-19","filed_date":"2021-04-21","scope":"insider","n_lines":4},{"id":4774536,"accession":"0001209191-21-016070","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-016070","line_url":"/filing/0001209191-21-016070","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478448","owner_name":"MCCOURT Thomas A","owner_display_name":"MCCOURT Thomas A","owner_url":"/insider/0001478448","role":"Officer (President)","role_mark":"O","role_mark_label":"Officer (President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14685.0,"shares_display":"14,685","price_per_share":9.11,"price_display":"9.11","price_state":"stated","total_value":133780.35,"total_display":"133,780.35","total_whole":"133,780","shares_owned_after":471577.0,"shares_owned_after_display":"471,577","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-26","filed_date":"2021-03-02","scope":"insider","n_lines":3},{"id":3145445,"accession":"0001179110-20-009770","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001179110-20-009770","line_url":"/filing/0001179110-20-009770","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001478448","owner_name":"MCCOURT Thomas A","owner_display_name":"MCCOURT Thomas A","owner_url":"/insider/0001478448","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23272.0,"shares_display":"23,272","price_per_share":90.38612581643176,"price_display":"90.39","price_state":"stated","total_value":2103465.92,"total_display":"2,103,465.92","total_whole":"2,103,466","shares_owned_after":4622.0,"shares_owned_after_display":"4,622","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-11","filed_date":"2020-09-15","scope":"insider","n_lines":3},{"id":2040915,"accession":"0001209191-20-028903","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-028903","line_url":"/filing/0001209191-20-028903#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478448","owner_name":"MCCOURT Thomas A","owner_display_name":"MCCOURT Thomas A","owner_url":"/insider/0001478448","role":"Officer (President)","role_mark":"O","role_mark_label":"Officer (President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1697.0,"shares_display":"1,697","price_per_share":10.35,"price_display":"10.35","price_state":"stated","total_value":17563.95,"total_display":"17,563.95","total_whole":"17,564","shares_owned_after":319847.0,"shares_owned_after_display":"319,847","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-11","filed_date":"2020-05-13","scope":"insider"},{"id":2679694,"accession":"0001209191-20-012490","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-012490","line_url":"/filing/0001209191-20-012490","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478448","owner_name":"MCCOURT Thomas A","owner_display_name":"MCCOURT Thomas A","owner_url":"/insider/0001478448","role":"Officer (President)","role_mark":"O","role_mark_label":"Officer (President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4177.0,"shares_display":"4,177","price_per_share":11.63,"price_display":"11.63","price_state":"stated","total_value":48578.51,"total_display":"48,578.51","total_whole":"48,579","shares_owned_after":222927.0,"shares_owned_after_display":"222,927","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-21","filed_date":"2020-02-25","scope":"insider","n_lines":2},{"id":2186016,"accession":"0001209191-20-005129","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-005129","line_url":"/filing/0001209191-20-005129#line-2","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478448","owner_name":"MCCOURT Thomas A","owner_display_name":"MCCOURT Thomas A","owner_url":"/insider/0001478448","role":"Officer (President)","role_mark":"O","role_mark_label":"Officer (President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":12.71,"price_display":"12.71","price_state":"stated","total_value":254200.0,"total_display":"254,200.00","total_whole":"254,200","shares_owned_after":225239.0,"shares_owned_after_display":"225,239","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-24","filed_date":"2020-01-28","scope":"insider"},{"id":8028077,"accession":"0001209191-19-048225","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-048225","line_url":"/filing/0001209191-19-048225#line-3","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478448","owner_name":"MCCOURT Thomas A","owner_display_name":"MCCOURT Thomas A","owner_url":"/insider/0001478448","role":"Officer (President)","role_mark":"O","role_mark_label":"Officer (President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":220000.0,"shares_display":"220,000","price_per_share":9.24,"price_display":"9.24","price_state":"stated","total_value":2032800.0,"total_display":"2,032,800.00","total_whole":"2,032,800","shares_owned_after":109739.0,"shares_owned_after_display":"109,739","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-30","filed_date":"2019-09-04","scope":"insider"},{"id":7789112,"accession":"0001209191-19-029609","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-029609","line_url":"/filing/0001209191-19-029609#line-1","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478448","owner_name":"MCCOURT Thomas A","owner_display_name":"MCCOURT Thomas A","owner_url":"/insider/0001478448","role":"Officer (President)","role_mark":"O","role_mark_label":"Officer (President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4055.0,"shares_display":"4,055","price_per_share":10.53,"price_display":"10.53","price_state":"stated","total_value":42699.15,"total_display":"42,699.15","total_whole":"42,699","shares_owned_after":107239.0,"shares_owned_after_display":"107,239","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-10","filed_date":"2019-05-14","scope":"insider"},{"id":8189973,"accession":"0001209191-19-012651","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-19-012651","line_url":"/filing/0001209191-19-012651","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478448","owner_name":"MCCOURT Thomas A","owner_display_name":"MCCOURT Thomas A","owner_url":"/insider/0001478448","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":41.0,"shares_display":"41","price_per_share":14.32,"price_display":"14.32","price_state":"stated","total_value":587.12,"total_display":"587.12","total_whole":"587","shares_owned_after":83323.0,"shares_owned_after_display":"83,323","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-21","filed_date":"2019-02-22","scope":"insider","n_lines":3},{"id":8189956,"accession":"0001209191-19-012651","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-012651","line_url":"/filing/0001209191-19-012651#line-3","is_derivative":false,"issuer_cik":"0001446847","issuer_name":"IRONWOOD PHARMACEUTICALS INC","issuer_ticker":"IRWD","issuer_name_source":null,"issuer_url":"/issuer/0001446847","owner_cik":"0001478448","owner_name":"MCCOURT Thomas A","owner_display_name":"MCCOURT Thomas A","owner_url":"/insider/0001478448","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1957.0,"shares_display":"1,957","price_per_share":14.31,"price_display":"14.31","price_state":"stated","total_value":28004.67,"total_display":"28,004.67","total_whole":"28,005","shares_owned_after":84981.0,"shares_owned_after_display":"84,981","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-20","filed_date":"2019-02-22","scope":"insider"}],"collapsed":true,"next_cursor":"2019-02-20|8189956","ledger_fault":false,"count":{"value":59,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":59,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":59},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001446847","name":"IRONWOOD PHARMACEUTICALS INC","url":"/issuer/0001446847","role":"Director, Officer (Chief Executive Officer)","n_filings":34,"first_seen":"2013-03-13","last_seen":"2026-02-25"},{"type":"issuer","type_label":"ISSUER","cik":"0001280600","name":"ACCELERON PHARMA INC","url":"/issuer/0001280600","role":"Director","n_filings":2,"first_seen":"2020-09-15","last_seen":"2021-04-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001478448","retrieved_at":"2026-08-25T18:00:51+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}